BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 26771744)

  • 1. Simultaneous BK Polyomavirus (BKPyV)-associated nephropathy and hemorrhagic cystitis after living donor kidney transplantation.
    Helanterä I; Hirsch HH; Wernli M; Ortiz F; Lempinen M; Räisänen-Sokolowski A; Auvinen E; Mannonen L; Lautenschlager I
    J Clin Virol; 2016 Mar; 76():4-7. PubMed ID: 26771744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human polyomavirus BK (BKPyV): virological background and clinical implications.
    Rinaldo CH; Tylden GD; Sharma BN
    APMIS; 2013 Aug; 121(8):728-45. PubMed ID: 23782063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
    Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
    Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe BK polyomavirus-induced hemorrhagic cystitis in a kidney transplant recipient with the absence of renal allograft involvement.
    Kamal M; Govil A; Anand M; Abu Jawdeh BG; Shah S
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29143415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
    Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BK Polyomavirus-associated nephropathy managed by screening policy in a real-life setting.
    Raupp FVV; Meinerz G; da Silva CK; Bianco PCD; Goldani JC; Pegas KL; Stolfo JB; Garcia VD; Keitel E
    Transpl Infect Dis; 2020 Feb; 22(1):e13213. PubMed ID: 31724282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HPyV9 and TSPyV coinfection on the development of BK polyomavirus viremia and associated nephropathy after kidney transplantation.
    van Rijn AL; Wunderink HF; de Brouwer CS; van der Meijden E; Rotmans JI; Feltkamp MCW
    J Med Virol; 2019 Jun; 91(6):1142-1147. PubMed ID: 30624811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor.
    Lorentzen EM; Henriksen S; Kaur A; Kro GB; Hammarström C; Hirsch HH; Midtvedt K; Rinaldo CH
    Virol J; 2020 Jan; 17(1):5. PubMed ID: 31924245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of BKPyV reactivation and risk of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.
    Höller K; Fabeni L; Herling M; Holtick U; Scheid C; Knops E; Lübke N; Kaiser R; Pfister H; Di Cristanziano V
    Eur J Haematol; 2017 Aug; 99(2):133-140. PubMed ID: 28401591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation.
    Korth J; Anastasiou OE; Bräsen JH; Brinkhoff A; Lehmann U; Kribben A; Dittmer U; Verheyen J; Wilde B; Ciesek S; Witzke O; Widera M
    J Clin Virol; 2019 Apr; 113():14-19. PubMed ID: 30771597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Apr; 35(4):625-631. PubMed ID: 31858227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
    Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of low-level BK polyomavirus viremia on intermediate-term renal allograft function.
    Korth J; Widera M; Dolff S; Guberina H; Bienholz A; Brinkhoff A; Anastasiou OE; Kribben A; Dittmer U; Verheyen J; Wilde B; Witzke O
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29156086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
    Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
    Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BK polyomavirus in kidney transplant recipients: screening, monitoring and clinical management.
    Varella RB; Almeida JR; Lopes Pde F; Matos JP; Menezes P; Lugon JR
    J Bras Nefrol; 2014; 36(4):529-34. PubMed ID: 25517283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable sources of Bk virus in renal allograft recipients.
    Urbano PRP; Nali LHDS; Oliveira RDR; Sumita LM; Fink MCDDS; Pierrotti LC; Bicalho CDS; David-Neto E; Pannuti CS; Romano CM
    J Med Virol; 2019 Jun; 91(6):1136-1141. PubMed ID: 30680753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse gastrointestinal bleeding and BK polyomavirus replication in a pediatric allogeneic haematopoietic stem cell transplant patient.
    Koskenvuo M; Lautenschlager I; Kardas P; Auvinen E; Mannonen L; Huttunen P; Taskinen M; Vettenranta K; Hirsch HH
    J Clin Virol; 2015 Jan; 62():72-4. PubMed ID: 25542476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.
    Dieplinger G; Everly MJ; Briley KP; Haisch CE; Bolin P; Maldonado AQ; Kendrick WT; Kendrick SA; Morgan C; Terasaki PI; Rebellato LM
    Transpl Infect Dis; 2015 Dec; 17(6):848-58. PubMed ID: 26442607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of human polyomaviruses, with HPyV7, BKPyV, and JCPyV present in urine of allogeneic hematopoietic stem cell transplanted patients with or without hemorrhagic cystitis.
    Franzén J; Ramqvist T; Bogdanovic G; Grün N; Mattson J; Dalianis T
    Transpl Infect Dis; 2016 Apr; 18(2):240-6. PubMed ID: 26809742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.